Bridging the gap between viable but non-culturable and antibiotic persistent bacteria

Trends in Microbiology

Volumn 23, Issue 1, 2015, Pages 7-13

  Ayrapetyan, Mesrop ^a   Williams, Tiffany C ^a   Oliver, James D ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Antibiotic; Bacterial persistence; Dormancy; Toxin antitoxin; VBNC

Indexed keywords

BACTERIAL PROTEIN; ENDOPEPTIDASE LA; GUANOSINE 3' DIPHOSPHATE 5' TRIPHOSPHATE; PROTEIN VAPB; PROTEIN VAPC; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL CELL; BACTERIAL DORMANCY; BACTERIAL GENETICS; BACTERIAL IMMUNITY; BACTERIAL PERSISTENCE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL SURVIVAL; BIOFILM FORMATION; CELLULAR STRESS RESPONSE; ENVIRONMENTAL STRESS; ESCHERICHIA COLI; HUMAN; MICROENVIRONMENT; NONHUMAN; PHENOTYPE; RECURRENT INFECTION; REVIEW; BACTERIUM; BIOFILM; DOSE RESPONSE; DRUG EFFECTS; ENVIRONMENT; GENETICS; MICROBIAL VIABILITY; MULTIDRUG RESISTANCE; PHYSIOLOGICAL STRESS;

BACTERIA (MICROORGANISMS);

ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENVIRONMENT; MICROBIAL VIABILITY; PHENOTYPE; STRESS, PHYSIOLOGICAL;

EID: 84920522058     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2014.09.004     Document Type: Review

References (68)

1. Abraham E.P., Chain E. An enzyme from bacteria able to destroy penicillin. Nature 1940, 146:837.
2. Colwell R.R. Survival strategies of bacteria in the natural environment. J. Infect. Chemother. 2000, 6:121-125.
3. Lennon J.T., Jones S.E. Microbial seed banks: the ecological and evolutionary implications of dormancy. Nat. Rev. Microbiol. 2011, 9:119-130.
4. Pinto D., et al. Resuscitation of Escherichia coli VBNC cells depends on a variety of environmental or chemical stimuli. J. Appl. Microbiol. 2011, 110:1601-1611.
5. Ayrapetyan M., et al. Interspecific quorum sensing mediates the resuscitation of viable but nonculturable vibrios. Appl. Environ. Microbiol. 2014, 80:2478-2483.
6. Nowakowska J., Oliver J.D. Resistance to environmental stresses by Vibrio vulnificus in the viable but nonculturable state. FEMS Microbiol. Ecol. 2013, 84:213-222.
7. Helaine S., Kugelberg E. Bacterial persisters: formation, eradication, and experimental systems. Trends. Microbiol. 2014, 1-8.
8. Oliver J.D. Recent findings on the viable but nonculturable state in pathogenic bacteria. FEMS Microbiol. Rev. 2010, 34:415-425.
9. Moyed H.S., Bertrand K.P. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 1983, 155:768-775.
10. Lafleur M.D., et al. Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob. Agents Chemother. 2010, 54:39-44.
11. Mulcahy L.R., et al. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J. Bacteriol. 2010, 192:6191-6199.
12. Fakruddin M., et al. Viable but nonculturable bacteria: food safety and public health perspective. ISRN Microbiol. 2013, 2013:703813.
13. Baffone W., et al. Campylobacter jejuni loss of culturability in aqueous microcosms and ability to resuscitate in a mouse model. Int. J. Food Microbiol. 2006, 107:83-91.
14. Baffone W., et al. Retention of virulence in viable but non-culturable halophilic Vibrio spp. Int. J. Food Microbiol. 2003, 89:31-39.
15. Oliver J.D., Bockian R. In vivo resuscitation, and virulence towards mice, of viable but nonculturable cells of Vibrio vulnificus. Appl. Environ. Microbiol. 1995, 61:2620-2623.
16. Rivers B., Steck T.R. Viable but nonculturable uropathogenic bacteria are present in the mouse urinary tract following urinary tract infection and antibiotic therapy. Urol. Res. 2001, 29:60-66.
17. Maisonneuve E., Gerdes K. Molecular mechanisms underlying bacterial persisters. Cell 2014, 157:539-548.
18. Li L., et al. The importance of the viable but non-culturable state in human bacterial pathogens. Front. Microbiol. 2014, 5:258.
19. Bigger J.W. Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet 1944, 244:497-500.
20. Lewis K. Persister cells. Annu. Rev. Microbiol. 2010, 64:357-372.
21. Balaban N.Q., et al. Bacterial persistence as a phenotypic switch. Science 2004, 305:1622-1625.
22. Maisonneuve E., et al. (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 2013, 154:1140-1150.
23. Orman M.A., Brynildsen M.P. Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob. Agents Chemother. 2013, 57:3230-3239.
24. Wakamoto Y., et al. Dynamic persistence of antibiotic-stressed mycobacteria. Science 2013, 339:91-95.
25. Xu H.S., et al. Survival and viability of nonculturable Escherichia coli and Vibrio cholerae in the estuarine and marine environment. Microb. Ecol. 1982, 8:313-323.
26. Fauvart M., et al. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J. Med. Microbiol. 2011, 60:699-709.
27. Lleo M.M., et al. Detecting the presence of bacterial DNA by PCR can be useful in diagnosing culture-negative cases of infection, especially in patients with suspected infection and antibiotic therapy. FEMS Microbiol. Lett. 2014, 354:153-160.
28. Amato S.M., et al. Metabolic control of persister formation in Escherichia coli. Mol. Cell 2013, 50:475-487.
29. Helaine S., et al. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 2014, 343:204-208.
30. Vega N.M., et al. Signaling-mediated bacterial persister formation. Nat. Chem. Biol. 2012, 8:431-433.
31. Wu Y., et al. Role of oxidative stress in persister tolerance. Antimicrob. Agents Chemother. 2012, 56:4922-4926.
32. Bernier S.P., et al. Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet. 2013, 9:e1003144.
33. Dorr T., et al. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 2010, 8:e1000317.
34. Chaveerach P., et al. Survival and resuscitation of ten strains of Campylobacter jejuni and Campylobacter coli under acid conditions. Appl. Environ. Microbiol. 2003, 69:711-714.
35. Day A.P., Oliver J.D. Changes in membrane fatty acid composition during entry of Vibrio vulnificus into the viable but nonculturable state. J. Microbiol. 2004, 42:69-73.
36. Xiao X.L., et al. Detection of viable but nonculturable Escherichia coli O157:H7 using propidium monoazide treatments and qPCR. Can. J. Microbiol. 2013, 59:157-163.
37. Besnard V., et al. Development of a direct viable count procedure for the investigation of VBNC state in Listeria monocytogenes. Lett. Appl. Microbiol. 2000, 31:77-81.
38. Orman M.A., Brynildsen M.P. Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob. Agents Chemother. 2013, 57:4398-4409.
39. Nguyen D., et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 2011, 334:982-986.
40. Stewart P.S., Franklin M.J. Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 2008, 6:199-210.
41. Steinert M., et al. Resuscitation of viable but nonculturable Legionella pneumophila Philadelphia JR32 by Acanthamoeba castellanii. Appl. Environ. Microbiol. 1997, 63:2047-2053.
42. Epstein S.S. Microbial awakenings. Nature 2009, 457:1083.
43. Keren I., et al. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 2004, 186:8172-8180.
44. Harshman R.B., Yamazaki H. Formation of ppGpp in a relaxed and stringent strain of Escherichia coli during diauxie lag. Biochemistry 1971, 10:3980-3982.
45. Dalebroux Z.D., Swanson M.S. ppGpp: magic beyond RNA polymerase. Nat. Rev. Microbiol. 2012, 10:203-212.
46. Akiyama M., et al. An exopolyphosphatase of Escherichia coli. The enzyme and its ppx gene in a polyphosphate operon. J. Biol. Chem. 1993, 268:633-639.
47. Akiyama M., et al. The polyphosphate kinase gene of Escherichia coli. Isolation and sequence of the ppk gene and membrane location of the protein. J. Biol. Chem. 1992, 267:22556-22561.
48. Mishra A., et al. Viability kinetics, induction, resuscitation and quantitative real-time polymerase chain reaction analyses of viable but nonculturable Vibrio cholerae O1 in freshwater microcosm. J. Appl. Microbiol. 2012, 112:945-953.
49. Boaretti M., et al. Involvement of rpoS in the survival of Escherichia coli in the viable but non-culturable state. Environ. Microbiol. 2003, 5:986-996.
50. Gangaiah D., et al. Importance of polyphosphate kinase 1 for Campylobacter jejuni viable-but-nonculturable cell formation, natural transformation, and antimicrobial resistance. Appl. Environ. Microbiol. 2009, 75:7838-7849.
51. Maisonneuve E., et al. Bacterial persistence by RNA endonucleases. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:13206-13211.
52. Gerdes K., Maisonneuve E. Bacterial persistence and toxin-antitoxin loci. Annu. Rev. Microbiol. 2012, 66:103-123.
53. Smith C.K., et al. Lon and Clp family proteases and chaperones share homologous substrate-recognition domains. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:6678-6682.
54. Gottesman S. Proteases and their targets in Escherichia coli. Annu. Rev. Genet. 1996, 30:465-506.
55. Diago-Navarro E., et al. Cleavage of the antitoxin of the parD toxin-antitoxin system is determined by the ClpAP protease and is modulated by the relative ratio of the toxin and the antitoxin. Plasmid 2013, 70:78-85.
56. Donegan N.P., et al. Proteolytic regulation of toxin-antitoxin systems by ClpPC in Staphylococcus aureus. J. Bacteriol. 2010, 192:1416-1422.
57. Alleron L., et al. VBNC Legionella pneumophila cells are still able to produce virulence proteins. Water Res. 2013, 47:6606-6617.
58. Kusumoto A., et al. Deletion in the C-terminal domain of ClpX delayed entry of Salmonella enterica into a viable but non-culturable state. Res. Microbiol. 2013, 164:335-341.
59. Rotem E., et al. Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12541-12546.
60. Conlon B.P., et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 2013, 503:365-370.
61. Davis C. Enumeration of probiotic strains: review of culture-dependent and alternative techniques to quantify viable bacteria. J. Microbiol. Methods 2014, 103C:9-17.
62. Cangelosi G.A., Meschke J.S. Dead or alive: molecular assessment of microbial viability. Appl. Environ. Microbiol. 2014, 80:5884-5891.
63. Christensen-Dalsgaard M., et al. Three new RelE-homologous mRNA interferases of Escherichia coli differentially induced by environmental stresses. Mol. Microbiol. 2010, 75:333-348.
64. Pedersen K., et al. Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins. Mol. Microbiol. 2002, 45:501-510.
65. Christensen-Dalsgaard M., Gerdes K. Two higBA loci in the Vibrio cholerae superintegron encode mRNA cleaving enzymes and can stabilize plasmids. Mol. Microbiol. 2006, 62:397-411.
66. Korch S.B., Hill T.M. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J. Bacteriol. 2006, 188:3826-3836.
67. Demidenok O.I., et al. Toxin-antitoxin vapBC locus participates in formation of the dormant state in Mycobacterium smegmatis. FEMS Microbiol. Lett. 2014, 352:69-77.
68. Oliver J.D. The viable but nonculturable state in bacteria. J. Microbiol. 2005, 43:93-100.